Coverage of cervical cancer screening in 57 countries: Low average levels and large inequalities

[1] Human papilloma virus (HPV) prophylactic vaccination: Challenges for public health and implications for screening [J]. VACCINE, 2007, 25 (16) : 3007 - 3013

[2] Cervical screening and health inequality in England in the 1990s [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2003, 57 (06) : 417 - 423

[3] Can we do the same in the developing world? [J]. GYNECOLOGIC ONCOLOGY, 2005, 99 (03) : S192 - S196

[4] BLUMENTHAL R, 2007, TEXAS LEGISLATORS BL

[5] Delivering cervical cancer prevention services in low-resource settings [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2005, 89 : S21 - S29

[6] Progress in cancer screening over a decade: Results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (22) : 1704 - 1713

[7] Brinkman JA, 2005, EUR J GYNAECOL ONCOL, V26, P129

[8] The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada [J]. VACCINE, 2007, 25 (29) : 5399 - 5408

[9] Castro-Jiménez Miguel A., 2006, Rev. salud pública, V8, P248, DOI 10.1590/S0124-00642006000300010

[10] Risk factors for cervical cancer in Thailand:: A case-control study [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (01) : 50 - 57

[1] Human papilloma virus (HPV) prophylactic vaccination: Challenges for public health and implications for screening [J]. VACCINE, 2007, 25 (16) : 3007 - 3013

[2] Cervical screening and health inequality in England in the 1990s [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2003, 57 (06) : 417 - 423

[3] Can we do the same in the developing world? [J]. GYNECOLOGIC ONCOLOGY, 2005, 99 (03) : S192 - S196

[4] BLUMENTHAL R, 2007, TEXAS LEGISLATORS BL

[5] Delivering cervical cancer prevention services in low-resource settings [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2005, 89 : S21 - S29

[6] Progress in cancer screening over a decade: Results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (22) : 1704 - 1713

[7] Brinkman JA, 2005, EUR J GYNAECOL ONCOL, V26, P129

[8] The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada [J]. VACCINE, 2007, 25 (29) : 5399 - 5408

[9] Castro-Jiménez Miguel A., 2006, Rev. salud pública, V8, P248, DOI 10.1590/S0124-00642006000300010

[10] Risk factors for cervical cancer in Thailand:: A case-control study [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (01) : 50 - 57